News | May 05, 2022
JBCPL emerges as the fastest growing pharma company: Report
Ranked 25th with an impressive growth rate of 29% among Indian pharma companies in FY 2021-22
Ranked 25th with an impressive growth rate of 29% among Indian pharma companies in FY 2021-22
The report has estimated 4.74 million deaths for India in 2020 and 2021,
The announcement follows FDA 510(k) clearance of device
CIVCO RT will also display its recent innovations focusing on improving patient comfort and outcomes
He will be leading the business, operations, P&L, and growth strategy for StanPlus
Onshore manufacturing facility is expected to be based in Quebec and produce up to 100 million mRNA respiratory vaccine doses annually
Flagship U.S. facility will include biologic manufacturing and late stage research and clinical development of innovative cancer medicines
Approval based on groundbreaking Phase 3 EXPLORER-HCM trial demonstrating benefit in patients receiving Camzyos versus placebo
It is expanding the diagnostics business footprint in North East India
The plant is expected to start commercial operations from Q4FY24
Subscribe To Our Newsletter & Stay Updated
